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Practical guide to sample size calculations:
superiority trials
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March 24, 2016
Abstract
A sample size justification is a vital part of any investigation. However,
estimating the number of participants required to give meaningful results
is not always as straightforward. A number of components are required to
facilitate a suitable sample size. Practical advice and examples are provided
illustrating how to carry out a the calculations by hand and using the app
SampSize.
1 Introduction
The introduction paper in this series highlighted the key general components
required to estimate the sample size of a clinical trial [1]. This paper provides
a practical guide for applying these steps to superiority parallel group clinical
trials where the primary endpoint can be assumed to be Normally distributed.
In a superiority trial, the objective is to determine whether there is evidence
of a difference in the comparator of interest between the regimens, with reference
to the null hypothesis that the regimens are the same.
This paper will go through the steps of a sample size calculation for a supe-
riority trial first giving an explanation of superiority trials and their hypotheses.
The formulae for sample size calculations are then given, highlighting how each
of the components forms part of the calculation.
Worked examples are used to demonstrate the operational steps in a sample
size calculation. The worked examples will use the app SampSize [2] and by-
hand solutions to emphasise the ease of calculation. Details of how to obtain the
app are provided in Table 1.
Table 1: How to obtain the app SampSize
The SampSize app is available on the Apple App Store to
download for free and can be used on iPod Touch, iPad and
iPhones. The app is also available on the Android Market.
It requires Android version 2.3.3 and above.
For the calculations in this paper, an iPad is used.
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2 Components of a Sample Size
In the introduction to this series, the steps needed for a sample size calculation
are identified. Table 2 gives a summary of these points. An important step
before carrying out any sample size calculation is being able to complete this
table.
Table 2: Summary of steps required for a sample size calculation,
Step Summary
Objective Is the trial aiming to show superior-
ity, non-inferiority or equivalence?
Endpoint What endpoint will be used to show
the primary outcome? Normal, bi-
nary, ordinal or time to event?
Error Type I error: How much chance are
you willing to take of rejecting the
null when it is actually true?
Type II error: How much chance are
you willing to take of not rejecting
the null when it is actually false?
Effect size What is the minimum difference
worth detecting?
Population Variance What is the population variability?
Other Do you need to account for
dropouts? How many patients meet
the inclusion criteria?
3 Superiority Clinical Trials
In a superiority trial, the objective is to determine whether there is evidence of
a difference in the desired outcome between treatment A and treatment B with
mean response A and B, respectively. The hypotheses under consideration are:
H0: The two treatments are not different with respect to the mean response
µA = µB.
H1: The two treatments are different with respect to the mean response
µA 6= µB.
For a superiority trial, the null hypothesis can be rejected if A > B or if
A < B by a statistically significant amount. This results in two chances of
making a type I error.
The statistical test is referred to as a two-tailed test with each tail allocated
an equal amount of the type I error (2.5%). The sum of these tails is equal to
the overall type I error rate of 5%. The null hypothesis can be rejected if the
test of A < B is statistically significant at the 2.5% level or the test of A > B is
statistically significant at the 2.5% level. This is illustrated in Figure 1.
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Figure 1: Density plot of superiority trial under the null hypothesis.
To design a two group trial, the sample size per arm can be estimated [3]
from the formula given in Figure 2.
The allocation ratio (r) is such that the number of participants on treatment
B is r times the number on treatment A, that is, nB = rnA. Note: n = nA+nB
is minimised when r = 1.
Table 3: Normal deviates for common percentiles.
x Z1−x
0.200 0.842
0.150 1.036
0.100 1.282
0.050 1.645
0.025 1.960
0.010 2.326
0.001 3.090
Table 3 gives common Normal deviates for different percentiles. For example,
for β = 0.1, we would have x = 0.1 and Z1−x = 1.282, while for α = 0.05, we
would have x = 0.025 and Z1−x = 1.96. These values are useful when calculating
a sample size by-hand.
Once the trial has been conducted, the data are collected and cleaned for
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Type II error (Ⱦ) Type I error (Ƚ) 
Population 
variance (ɐ2) 
 
Effect size (d) Allocation ratio (r) 
Figure 2: Formula to calculate the sample size for a superiority parallel group
trial with Normally distributed endpoint.
analysis, the population variance, σ2, is usually considered unknown for the
analysis, and a sample variance estimate, s2, is used instead. This is estimated
with nA(r+1)− 2 degrees of freedom. The following formula can be used [3],[4]
1− β = Probt
(
t1−α
2
−2, nA(r + 1)− 2),
√
rnAd2
(r + 1σ2
)
)
(1)
where Probt(·) is defined as the cumulative density function of a non-central t
distribution, taken from the function in the package SAS (SAS Institute, Inc.,
Cary, NC, USA). This result gives the power for a given sample size. To estimate
a sample size for a given power, we must iterate up the sample sizes until the
requisite power is reached. The SampSize app uses the non-central t distribution
in its calculations.
To assist, Table 4 gives sample sizes using (1) for various standardised dif-
ferences.
Although the formula in Figure 2 is easier to calculate by-hand, it gives
slightly lower sample sizes when compared with (1).
For quick calculations when we have 90% power and a two-sided 5% type I
error rate, the following result can be used:
nA =
10.5σ2
d2
(r + 1)
r
(2)
4
Table 4: Normal deviates for common percentiles.
δs 1 2 3 4
0.05 8407 6306 5605 5255
0.10 2103 1577 1402 1314
0.15 935 702 624 585
0.20 527 395 351 329
0.25 338 253 225 211
0.30 235 176 157 147
0.35 173 130 115 108
0.40 133 100 89 83
0.45 105 79 70 66
0.50 86 64 57 53
0.55 71 53 47 44
0.60 60 45 40 37
0.65 51 38 34 32
0.70 44 33 30 28
0.75 39 29 26 24
0.80 34 26 23 21
0.85 31 23 20 19
0.90 27 21 18 17
0.95 25 19 17 15
1.00 23 17 15 14
or for r = 1:
nA =
21σ2
d2
(3)
4 Cactus Example
In the CACTUS clinical trial [5], participants suffering from long-standing apha-
sia post stroke are to be randomised to one of three arms:
1. usual care,
2. self-managed computerised speech and language therapy in addition to
usual care and
3. attention control in addition to usual care.
The primary objective of the trial is to compare usual care with self-managed
computerised therapy. The primary outcome of interest is the change in the num-
ber of words named correctly at 6 months. The minimal clinically meaningful
difference is improvement in word retrieval of 10%. Based on a pilot study [5],
the population standard deviation is assumed to be 17.38%. The dropout rate
applied is 15% (95% confidence interval (CI), 5-32%).
Assuming 90% power, a two-sided type I error rate of 0.05 and an allocation
ratio of r = 1, we can go through the steps now to estimate the sample size.
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Table 5: Key components required for sample size.
Step Summary
Objective Superiority: H0 : µA = µB vs H1 : µA 6= µB
Endpoint Improvement in word retrieval (normal)
Error Type I error α = 0.05
Type II error β = 0.1, power 1− β = 0.9
Effect size d = 10%
Population Variance σ = 17.38%
Other r = 1
After identifying these key points summarised in Table 5, it is possible to
plug the values into the formula in Figure 2. This gives
nA =
(1 + 1)(Z1−0.1 + Z1−0.05/2)
2(17.382)
1× 102
(4)
Using the common percentiles from Table III, the sample size is 64 for each
group. To apply the 15% dropout rate, we divide by the completion rate (100%-
15%= 85%). This suggests that 76 participants are needed in each arm of the
trial.
The app SampSize can also be used for the calculation. To use the app,
you need to select options: Superiority, Parallel Group, Normal and Calculate
Sample Size. You then get to the top screen as given Figure 3.
Each component of the sample size calculation can be entered into the app.
For ease, the app provides a list of suggested entries you can select from. For
example (Figure 4), if you select Significance Level, the next screen gives the
options 0.001, 0.01, 0.02, 0.025, 0.03, 0.04, 0.05, 0.075 and 0.10 (sic). Alterna-
tively, you can select the Custom option where it is possible to enter a value for
the significance level manually.
SampSize gives a sample size of 65 per group. Applying the 15% dropout
rate, a total of 154 participants are required to achieve 90% power. The difference
in the two sample size estimates arises because SampSize uses a non-central t
distribution to estimate the sample size.
To use the sample size table, we first need to estimate the standardised
difference,
δ =
d
σ
=
10
17.38
= 0.575 (5)
Unfortunately, when using the tables, the standardised differences increase in
increments of 0.05. As a result, there is no entry in Table 4 for this standardised
difference. Standardised differences of δ = 0.55 and δ = 0.60 give sample sizes
of 71 and 60, respectively. A sample size of 71 is a conservative estimate, which
we would need to amend using SampSize or other calculations.
The 95% CI for the dropout rate suggests this value might be as low as 5%
or as high as 32%. If we design the study and estimate the evaluable sample size
to be 65 (as in the preceding text), accounting for a 15% dropout rate, we need
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to recruit 77 patients per arm. However, once the trial has begun, we experience
a much higher dropout rate of 32%, and our evaluable sample size decreases to
53. We can use the app to estimate the power of our study with this smaller
sample size.
As before, select a Superiority, Parallel Group trial with a Normal endpoint,
but now rather than choosing to calculate a sample size, select to calculate
power. With the same inputs as before but with a sample size of 53, the power
is estimated to be 83%. Although this is still an acceptable power, it is much
less than the proposed 90% power.
Figure 3: Screenshot of SampSize app custom settings for a sample size calcula-
tion.
This worked example illustrates how our power and sample size are sensitive
to the dropout rate, and so, attempts to estimate this rate in the planning of
the trial should be made. This might be based on the experiences of previous
trials recruiting similar patients as with the worked example here or based on
similar interventions.
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Figure 4: Screenshot of SampSize app for CACTUS worked example.
5 Summary
This paper has illustrated how to calculate sample sizes for superiority trials
where the data are assumed to be Normally distributed. It builds on the steps
identified in the first paper of the series for sample size estimation. The paper
gives formulae for sample size estimation from quick easy-to-use results to more
complicated calculations that require iteration to find a solution. To assist in
the calculations, sample size tables and calculations using an app SampSize are
described.
The subsequent papers in the series applies these ideas to non-inferiority and
equivalence [6].
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